Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;99(1):115183.
doi: 10.1016/j.diagmicrobio.2020.115183. Epub 2020 Aug 21.

Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19

Affiliations

Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19

François Caméléna et al. Diagn Microbiol Infect Dis. 2021 Jan.

Abstract

The FilmArray® Pneumonia Plus (FA-PP) panel can provide rapid identifications and semiquantitative results for many pathogens. We performed a prospective single-center study in 43 critically ill patients with coronavirus disease 2019 (COVID-19) in which we performed 96 FA-PP tests and cultures of blind bronchoalveolar lavage (BBAL). FA-PP detected 1 or more pathogens in 32% (31/96 of samples), whereas culture methods detected at least 1 pathogen in 35% (34/96 of samples). The most prevalent bacteria detected were Pseudomonas aeruginosa (n = 14) and Staphylococcus aureus (n = 11) on both FA-PP and culture. The FA-PP results from BBAL in critically ill patients with COVID-19 were consistent with bacterial culture findings for bacteria present in the FA-PP panel, showing sensitivity, specificity, and positive and negative predictive value of 95%, 99%, 82%, and 100%, respectively. Median turnaround time for FA-PP was 5.5 h, which was significantly shorter than for standard culture (26 h) and antimicrobial susceptibility testing results (57 h).

Keywords: Bacterial pneumonia; FilmArray Pneumonia Plus; Rapid diagnostics; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Competing interests F.C. received conference invitations from BioMérieux.

References

    1. Alhazzani W., Møller M.H., Arabi Y.M., Loeb M., Gong M.N., Fan E. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020:1–41. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed
    1. Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K. Covid-19 in critically ill patients in the Seattle region—case series. N Engl J Med. 2020:1–11. doi: 10.1056/NEJMoa2004500. - DOI - PMC - PubMed
    1. Clavel M, Barraud O, Moucadel V, Meynier F, Karam E, Ploy M-C, et al. Molecular quantification of bacteria from respiratory samples in patients with suspected ventilator-associated pneumonia. Clin Microbiol Infect 2016;22:812.e1–812.e7. doi:10.1016/j.cmi.2016.06.013. - DOI - PubMed
    1. Cornaglia G., Courcol R., Herrmann J. European Society for Clinical Microbiology and Infectious Diseases; Basel: 2012. European manual of clinical microbiology.
    1. Lee S.H., Ruan S.-Y., Pan S.-C., Lee T.-F., Chien J.-Y., Hsueh P.-R. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J Microbiol Immunol Infect. 2019;52:920–928. doi: 10.1016/j.jmii.2019.10.009. - DOI - PMC - PubMed